Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]

Share this

Date

2019

Author

Castillo E.

Prada-Arismendy J.

Metadata

Show full item record

Source

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073739486&doi=10.15446%2frevfacmed.v67n3.68417&partnerID=40&md5=7c45a39e018fe8d40526746065db9a08

URI

http://hdl.handle.net/20.500.12622/3143

Collections

• Artículos [930]